Johnson & Johnson (JNJ) Tops Q2 EPS by 12c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Johnson & Johnson (JNJ) PT Lowered to $146 at Raymond James
July 17, 2019 7:12 AM EDTRaymond James analyst Jayson Bedford lowered the price target on Johnson & Johnson (NYSE: JNJ) to $146.00 (from $147.00) while maintaining an Outperform rating.
Still a Lot of Drama, but Solid Fundamentals, Attractive Valuation
... More